CRISPR is a gigantic leap forward in simplifying and expediting gene editing across the board. It has also significantly reduced the cost. The tools, such as SHERLOCK from Broad, that are already cropping up around CRISPR are well beyond what was previously possible.
China as one example has found it so easy and inexpensive to work with, they're likely to rapidly leap ahead of the West in gene editing due to their willingness to allow for higher rates of risk. They'll have perhaps dozens of human trials under way by the end of 2017 / mid 2018. Just on the back of CRISPR they're going to go from lagging far behind in biotech, to being a global leader within two decades. Technologically they're going to skip the decades of traditional pharma / biotech build-up, as with jumping to cellphones and bypassing landlines.